Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

NCT05554913 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Thrombocytopenia

Interventions

DRUG: QL0911
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.